JoinCare said it has completed a new strategic seed round with participation from Titans Ventures, DI Foundation, and Candaq Ventures. According to ChainCatcher, the financing will be used to upgrade JoinCare's core infrastructure and CareAgents AI-assisted research system, expand its global network of early-stage biopharmaceutical projects and scientific and medical advisers, and advance its ecosystem applications and launchpad development.
JoinCare said it is building an open DeSci incubation network for early biopharmaceutical innovation by connecting research teams, scientific and medical experts, ecosystem builders, and community members. The company plans to extend the system to research institutions and innovation teams worldwide and create an AI-driven distributed biopharmaceutical innovation network.